Evaluating cognitive impairment in the clinical setting: Practical screening and Assessment tools

Topics in Antiviral Medicine

Volumn 19, Issue 5, 2011, Pages 175-180

  Valcour, Victor G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; ASYMPTOMATIC DISEASE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; COGNITIVE DEFECT; FEMALE; GENETICS; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNITED STATES; VIROLOGY;

AIDS DEMENTIA COMPLEX; ASYMPTOMATIC DISEASES; CENTRAL NERVOUS SYSTEM; COGNITION DISORDERS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 84861819507     PISSN: 21615861     EISSN: 21615853     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789-1799.
2. McArthur JC, Haughey N, Gartner S, et al. Human immunodeficiency virusassociated dementia: an evolving disease. J Neurovirol. 2003;9:205-221.
3. Valcour V, Paul R, Chiao S, Wendelken LA, Miller B. Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis. 2011;53:836-842.
4. Ganasen KA, Fincham D, Smit J, Seedat S, Stein D. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. J Neurol Sci. 2008;269:62-64.
5. Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Med. 2009;10:246-252.
6. Davis HF, Skolasky RL, Jr., Selnes OA, Burgess DM, McArthur JC. Assessing HIVassociated dementia: modified HIV dementia scale versus the Grooved Pegboard. AIDS Read. 2002;12:29-31, 38.
7. Smith CA, van Gorp WG, Ryan ER, Ferrando SJ, Rabkin J. Screening subtle HIVrelated cognitive dysfunction: the clinical utility of the HIV dementia scale. JAIDS. 2003;33:116-118.
8. Morgan EE, Woods SP, Scott JC, et al. Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. J Clin Exp Neuropsychol. 2008;30:83-90.
9. Waldrop-Valverde D, Nehra R, Sharma S, et al. Education effects on the International HIV Dementia Scale. J Neurovirol. 2010;16:264-267.
10. Overton ET, Ances B, Grubb J, et al. Novel screening tools for HIV-associated neurocognitive disorders. [Abstract 401.] 18th Conference on Retroviruses and Infections (CROI). February 27-March 2, 2011; Boston, MA.
11. Heaton RK, Clifford DB, Franklin DR, Jr., et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75:2087-2096.
12. Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317-331.
13. Nasreddine Z. The Montreal Cognitive Assessment. http://www.mocatest.org. Accessed October 19, 2011.
14. Marra CM, Zhao Y, Clifford DB, et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009;23:1359-1366.
15. Wendel KA, McArthur JC. Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication. Clin Infect Dis. 2003;37:1107-1111.
16. Canestri A, Lescure FX, Jaureguiberry S, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis. 2010;50:773-778.
17. Letendre S, FitzSimons C, Ellis R, et al. Correlates of CSF viral loads in 1221 volunteers of the CHARTER cohort. [Abstract 172]. 17th Conference on Retroviruses and Infections (CROI). February 16-19, 2010; San Francisco, CA.
18. Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011;19:137-142.